| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 宋嘉吉 | 国盛证券 | 通信 | 65.71% | 53.16% | 59.70% | 12.96% | 16 | -51.04% | 2025-09-08 |
| 2 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 68.47% | 23.49% | -2.86% | 0 | -56.96% | 2025-07-03 |
| 3 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 70.58% | 37.85% | -2.86% | 0 | -56.96% | 2025-07-08 |
| 4 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 36.56% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-18 |
| 5 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 18.08% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-13 |
| 6 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 23.01% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-12 |
| 7 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 13.96% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-11 |
| 8 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 68.98% | 42.97% | -2.86% | 0 | -56.96% | 2025-07-07 |
| 9 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 34.98% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-19 |
| 10 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 68.47% | 23.49% | -2.86% | 0 | -56.96% | 2025-07-04 |
| 11 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 13.96% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-10 |
| 12 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 58.82% | 39.79% | -2.86% | 0 | -56.96% | 2025-06-17 |
| 13 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 60.15% | 36.56% | -2.86% | 0 | -56.96% | 2025-06-18 |
| 14 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 63.07% | 34.98% | -2.86% | 0 | -56.96% | 2025-06-19 |
| 15 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 19.60% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-07 |
| 16 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 12.88% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-06 |
| 17 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-05 |
| 18 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-04 |
| 19 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-03 |
| 20 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 67.80% | 21.18% | -2.86% | 0 | -56.96% | 2025-07-02 |